Coronary microcirculatory vasodilator function in relation to risk factors among patients without obstructive coronary disease and low to intermediate Framingham score
Ronen Rubinshtein(Mayo Clinic), A. Lerman(Mayo Clinic), Eunice Yang(Alaska Heart and Vascular Institute), Lilach O. Lerman(Mayo Clinic), Ryan J. Lennon(University of Minnesota Rochester), Phillip J. Best(Mayo Clinic), Abhiram Prasad(Mayo Clinic), Charanjit S. Rihal(Mayo Clinic)
Cited by 84
Related Papers
Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease
|EBioMedicine|2019|1.3k
In Vivo Diagnosis of Plaque Erosion and Calcified Nodule in Patients With Acute Coronary Syndrome by Intravascular Optical Coherence Tomography
|Journal of the American College of Cardiology|2013|840
Endothelin in human congestive heart failure.
|Circulation|1994|588
Health-Related Quality of Life After Transcatheter or Surgical Aortic Valve Replacement in High-Risk Patients With Severe Aortic Stenosis
|Journal of the American College of Cardiology|2012|295